m****g
发帖数: 530 | 1 THE WOODLANDS, Texas--(BUSINESS WIRE)--Aug 7, 2009 - Opexa Therapeutics, Inc
. (NASDAQ:OPXA), a
company developing a novel T-cell immunotherapy for multiple sclerosis (MS),
today announced that it has
entered into an exclusive agreement with Novartis, one of the world's
largest pharmaceutical companies,
for the further development of Opexa's novel stem cell technology. This
technology, which has generated
preliminary data showing the potential to generate monocyte derived islet
cells from periph |
|
